1. Turkey Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
TAPDI OKSIJEN OZEL SAGLIK VE EGITIM HIZMETLERI SANAYI TICARET A.S.

TAPDI OKSIJEN OZEL SAGLIK VE EGITIM HIZMETLERI SANAYI TICARET A.S.

BBIST:TNZTP
22.94
TRY
-0.26
(-1.12%)
1.12EPS
22.40P/E
10.04BMarket Cap
TAPDI OKSIJEN OZEL SAGLIK VE EGITIM HIZMETLERI SANAYI TICARET A.S.
BIST:TNZTP
(Istanbul Exchange)

Recent

price

22.94

P/E

ratio

22.40

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
TRY
0.28
0.51
0.77
2.69
4.74
7.16
8.57
9.43
Revenue per Share
0.06
0.09
0.16
0.67
2.97
4.12
1.74
1.12
Basic EPS, GAAP
0.16
0.14
0.19
0.01
0.85
-2.62
0.75
0.46
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.16
- -
- -
- -
Dividend per Share
- -
- -
1.44
4.47
17.74
17.92
20.02
23.82
Book Value per Share
- -
- -
1.44
4.46
17.73
17.92
20
23.79
Tangible Book Value per Share
400
400
400
400
400
400
400
400
Basic Weighted Avg Shares
113
202
310
1,075
1,896
2,864
3,430
3,772
Sales/Revenue/Turnover
21.25
20.33
12.58
15.73
12.42
-3.28
28.41
28.58
Operating Margin (%)
- -
- -
12
77
200
255
198
213
Depreciation Expense
23
37
66
266
1,188
1,649
696
448
Net Income, GAAP
11.68
19.95
10.25
10.61
13.71
28.33
3.79
34.24
Effective Tax Rate (%)
20.32
18.39
21.27
24.76
62.65
57.58
20.28
11.88
Profit Margin (%)
- -
- -
120
278
266
231
485
1,320
Working Capital
- -
- -
8
22
763
338
40
317
LT Debt
- -
- -
574
1,786
4,486
7,170
8,009
9,532
Total Equity
- -
- -
- -
12.95
5.72
5.58
11.49
8.45
Return on Invested Capital (%)
- -
- -
- -
24.04
34.53
29.47
12.75
8.27
Return on Capital (%)
- -
- -
- -
22.54
37.88
28.3
9.17
5.5
Return on Common Equity (%)

Capital Structure

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
350
315
357
LT Borrowings
40
18
9
LT Finance Leases
- -
488
308
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
400
400
400
Market Capitalization
8,176
8,600
10,040

Working Capital

TRY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,357
2,156
2,220
Cash, Cash Equivalents & STI
724
1,365
1,462
Accounts Receivable, Net
362
460
451
Inventories
112
114
126
Total Current Liabilities
872
910
900
Payables & Accruals
- -
- -
- -
ST Debt
350
315
357
Deferred Revenue
- -
- -
- -

Growth Rates

TRY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
11.7%
Free Cash Flow
- -
1,752.34%
-128.58%
Net Income, GAAP
- -
141.75%
-57.81%
Sales/Revenue/Turnover
- -
89.53%
19.75%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
611
593
703
661
2,864
2025
941
958
846
985
3,430
2026
969
973
- -
- -
- -

Quarterly Earnings Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.25
3.32
-0.72
0.8
4.12
2025
0.22
0.82
0.19
0.69
1.74
2026
0.18
0.06
- -
- -
- -

Quarterly Dividends Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
0.23
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret A.S. is a Turkey-based healthcare and education services provider that operates comprehensive multi-specialty hospital networks, outpatient clinics, and specialized diagnostic centers under the Tinaztepe Health Group brand. Founded in 1999 and headquartered in Izmir, Turkey, the company delivers integrated inpatient and outpatient clinical services across a wide spectrum of therapeutic fields. Its primary healthcare offerings include cardiovascular surgery; cardiology; medical and radiation oncology; orthopedics and traumatology; neurology and neurosurgery; general surgery; obstetrics and gynecology; pediatrics; internal medicine; ophthalmology; urology; physical medicine and rehabilitation; adult, coronary, cardiovascular, and neonatal intensive care units; emergency medical services; advanced medical imaging and radiology; and clinical biochemistry, microbiology, and pathology laboratory services. The company operates major medical campuses across the Izmir metropolitan region, including Tinaztepe Buca Hospital, Tinaztepe Torbali Hospital, Tinaztepe Galen Hospital in Bayrakli, and associated outpatient medical centers, while catering to international patients through dedicated medical tourism programs. In addition to clinical care, the company supports academic and vocational healthcare training programs through its affiliations with Izmir Tinaztepe University. In recent developments, the company completed its initial public offering on Borsa Istanbul under the ticker symbol TNZTP, accelerated capital investments in solar energy generation projects to fulfill the electricity demands of its healthcare facilities sustainably, broadened its international patient network across Europe and the Middle East, and expanded its clinical capacity through modernizations of diagnostic imaging infrastructure and specialized surgical suites.